Abstract

Negative regulation of the NF-κB transcription factor is essential for tissue homeostasis in response to stress and inflammation. NF-κB activity is regulated by a variety of biochemical mechanisms including phosphorylation, acetylation, and ubiquitination. In this study, we provide the first experimental evidence that NF-κB is regulated by SUMOylation, where the RelA subunit of NF-κB is SUMOylated by PIAS3, a member of the PIAS (protein inhibitor of activated STAT) protein family with E3 SUMO ligase activity. PIAS3-mediated NF-κB repression was compromised by either RelA mutant resistant to SUMOylation or PIAS3 mutant defective in SUMOylation. PIAS3-mediated SUMOylation of endogenous RelA was induced by NF-κB activation thus forming a negative regulatory loop. The SUMOylation of endogenous RelA was enhanced in IκBα null as compared with wild type fibroblasts. The RelA SUMOylation was induced by TNFα but not leptomycin B mediated RelA nuclear translocation. Furthermore, RelA mutants defective in DNA binding were not SUMOylated by PIAS3, suggesting that RelA DNA binding is a signal for PIAS3-mediated SUMOylation. These results support a novel negative feedback mechanism for NF-κB regulation by PIAS3-mediated RelA SUMOylation.

Highlights

  • NF-kB is a transcription factor that mediates cellular response to inflammation, immune response, and stress [1]

  • RelA SUMOylation by PIAS3 To determine whether RelA is SUMOylated by PIAS

  • To test whether endogenous RelA is SUMOylated by PIAS3, we evaluated RelA SUMOylation by in vivo SUMOylation assay in 3T3 cells transiently transfected with Flag-tagged PIAS and Histagged SUMO3

Read more

Summary

Introduction

NF-kB is a transcription factor that mediates cellular response to inflammation, immune response, and stress [1]. Deregulation of NF-kB is one of the common features in many pathological disorders including inflammatory diseases and cancer. NF-kB is a dimeric protein which can be comprised of a variety of combinations of Rel family DNA binding proteins including RelA (p65), RelB, c-Rel, p50, and p52. A heterodimer of RelA and p50 is the most common combination in the canonical NFkB signaling pathway. NF-kB is held in check by the inhibitor of NF-kB (IkBa) which sequesters NF-kB in the cytoplasm and prevents NF-kB DNA binding. IkBa is phosphorylated by IkB kinases, leading to its degradation. The degradation of IkBa allows the free NF-kB to translocate to the nucleus where it functions as a transcription factor to induce the expression of proinflammatory cytokines, chemokines, and factors for cell proliferation and survival [2]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call